4.3 Article

Does heterogeneity matter in the estimation of tumour budding and tumour stroma ratio in colon cancer?

Journal

DIAGNOSTIC PATHOLOGY
Volume 13, Issue -, Pages -

Publisher

BIOMED CENTRAL LTD
DOI: 10.1186/s13000-018-0697-9

Keywords

Colon cancer; Heterogeneity; Tumour budding; Tumour stroma ratio

Categories

Funding

  1. Research Council of Lillebaelt Hospital
  2. Beckett Foundation
  3. Danish Cancer Research Foundation

Ask authors/readers for more resources

Background: Tumour budding (TB) and Tumour Stroma Ratio (TSR) may be rewarding in the treatment stratification of patients with stage II colon cancer. However, lack of standardization may exclude these parameters from being used in a clinical setting. The purpose of this methodologic study was to compare stereology with semi-quantitative estimations of TSR, to investigate the intra-tumoural heterogeneity of TB and TSR, and to assess the intra-and inter-observer agreement. Methods: Three paraffin embedded tumour blocks, one of them representing the deepest invasive front, were selected from each of 43 patients treated for stage II colon cancer. TSR was estimated in H&E sections semi-quantitatively using conventional microscopy, and stereologically on scanned slides, using the newCAST stereology platform. TB was scored across 10 high power fields at the invasive front in cytokeratin AE1/AE3 stained sections. Results: Subjective, semi-quantitative estimates of TSR significantly correlated to the stereological estimates, with the best correlation found for sections with the deepest invasive tumour penetration (sigma = 0.621, p < 0.001). Inter-observer agreement was moderate to substantial for both TB (Kappa = 0.46-0.73) and TSR (Kappa = 0.70-0.75). The Intraclass correlation coefficient (ICC) for TSR varied from 0.322 based on stereological hotspot estimation to 0.648 for the semi-quantitative evaluation. For TB, ICC varied from 0.646 based on continuous data to 0.698 based on categorical data (cut-off: 10 buds). Thus, the intra-tumoural heterogeneity for both TB and the semi-quantitative estimation of TSR was low. Conclusion: We recommend using only one tissue section representing the deepest invasive tumour area for estimation of TSR. For TB we recommend using one tissue section; however due to low representation of high-budding tumours, results must be considered with caution.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Oncology

The Prognostic Importance of ctDNA in Rectal Cancer: A Critical Reappraisal

Edina Dizdarevic, Torben Frostrup Hansen, Anders Jakobsen

Summary: An individualized treatment approach is crucial for improving survival and quality of life in rectal cancer, with circulating tumor DNA (ctDNA) showing promise as a useful tool for stratifying patients. However, current results are conflicting and lack standardization, highlighting the need for further studies to address bias and heterogeneity in reporting. Despite an association between ctDNA status and outcome, the field of research is still new with limited dedicated studies, underscoring the importance of standardization in ctDNA research for future advancements.

CANCERS (2022)

Review Oncology

Cell Free Methylated Tumor DNA in Bronchial Lavage as an Additional Tool for Diagnosing Lung Cancer-A Systematic Review

Sara Witting Christensen Wen, Jan Wen, Torben Frostrup Hansen, Anders Jakobsen, Ole Hilberg

Summary: Lung cancer is the leading cause of cancer-related deaths and is often diagnosed at an advanced stage. Detecting methylated tumor DNA in bronchial lavage fluid may help improve diagnostics and survival rates. However, the existing evidence on this biomarker is limited, indicating a need for prospective clinical trials to assess its applicability.

CANCERS (2022)

Article Medicine, Research & Experimental

Natural killer cell activity as a biomarker for the diagnosis of lung cancer in high-risk patients

Morten Borg, Sara Witting Christensen Wen, Torben Frostrup Hansen, Anders Jakobsen, Rikke Fredslund Andersen, Ole Hilberg, Ulla Moller Weinreich, Line Nederby

Summary: This study examined the relationship between NK cell activity and lung cancer in a high-risk cohort. The results showed significantly lower NK cell activity in patients with late-stage lung cancer compared to controls, suggesting a potential correlation between NK cell activity and advanced lung cancer.

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2022)

Article Pediatrics

Possible prediction of obesity-related liver disease in children and adolescents using indices of body composition

Magnus Jung Johansen, Morten Asp Vonsild Lund, Lars Angquist, Cilius Esmann Fonvig, Louise Aas Holm, Elizaveta Chabanova, Henrik S. Thomsen, Torben Hansen, Jens-Christian Holm

Summary: Body composition indices and alanine transaminase can be used to estimate the prevalence of non-alcoholic fatty liver disease in children and adolescents. In this study, the final models included five variables, with a sensitivity ranging from 38.6% to 51.7% and specificity ranging from 87.6% to 91.9%.

PEDIATRIC OBESITY (2022)

Letter Oncology

OPTIMISE: Optimisation of treatment selection and follow-up in oligometastatic colorectal cancer - a ctDNA-guided phase II randomised approach. Study protocol

Louise Bach Callesen, Torben Frostrup Hansen, Rikke Fredslund Andersen, Niels Pallisgaard, Stine Kramer, Sven Schlander, Soren Rafael Rafaelsen, Anders Kindberg Boysen, Lars Henrik Jensen, Anders Jakobsen, Karen-Lise Garm Spindler

ACTA ONCOLOGICA (2022)

Article Oncology

Assessment of circulating biomarkers for detection of lung cancer in a high-risk cohort

Morten Borg, Line Nederby, Sara Witting Christensen Wen, Torben Frostrup Hansen, Anders Jakobsen, Rikke Fredslund Andersen, Ulla Moller Weinreich, Ole Hilberg

Summary: This study assessed the diagnostic properties of a biomarker panel consisting of CYFRA 21-1, CEA, and CA125 for lung cancer detection. The results showed that the biomarkers had high sensitivity and specificity for detecting lung cancer, but their ability to detect early-stage lung cancer was low.

CANCER BIOMARKERS (2023)

Article Oncology

Combining sCD163 with CA 19-9 Increases the Predictiveness of Pancreatic Ductal Adenocarcinoma

Liva K. K. Stuhr, Kasper Madsen, Astrid Z. Z. Johansen, Inna M. M. Chen, Carsten P. P. Hansen, Lars H. H. Jensen, Torben F. F. Hansen, Kirstine Klove-Mogensen, Kaspar R. R. Nielsen, Julia S. S. Johansen

Summary: The CA 19-9 blood test has been widely used as a biomarker for pancreatic ductal adenocarcinoma (PDAC), but new biomarkers are needed to improve diagnosis. In this study, we found that combining the CA 19-9 test with the sCD163 blood test provided better diagnostic results compared to CA 19-9 alone. These findings suggest that sCD163 could be a valuable diagnostic marker for PDAC.

CANCERS (2023)

Article Oncology

NK cell activity and methylated HOXA9 ctDNA as prognostic biomarkers in patients with non-small cell lung cancer treated with PD-1/PD-L1 inhibitors

Sara Witting Christensen Wen, Line Nederby, Rikke Fredslund Andersen, Torben Schjodt Hansen, Christa Haugaard Nyhus, Ole Hilberg, Anders Jakobsen, Torben Frostrup Hansen

Summary: Natural killer cell activity (NKA) and methylated HOXA9 circulating tumor DNA (ctDNA) can serve as prognostic biomarkers in patients with non-small cell lung cancer (NSCLC) treated with PD-1/PD-L1 inhibitors. Evaluating the NKA and ctDNA status after one treatment cycle can accurately predict patient survival.

BRITISH JOURNAL OF CANCER (2023)

Article Oncology

Precision medicine applied to metastatic colorectal cancer using tumor-derived organoids and in-vitro sensitivity testing: a phase 2, single-center, open-label, and non-comparative study

Lars Henrik Jensen, Silvia Regina Rogatto, Jan Lindebjerg, Birgitte Havelund, Cecilie Abildgaard, Luisa Matos do Canto, Chris Vagn-Hansen, Claus Dam, Soren Rafaelsen, Torben Frostrup Hansen

Summary: This study evaluated the feasibility and clinical outcomes of using patient-derived organoids for metastatic colorectal cancer patients with no satisfactory treatment options. The research found that half of the patients had no disease progression at two months by using sensitivity testing with drugs proven to be active in clinical trials. This study suggests that cancer patients may benefit from functional testing using tumor-derived organoids.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2023)

Correction Multidisciplinary Sciences

The power of genetic diversity in genome-wide association studies of lipids (vol 600, pg 675, 2021)

Sarah E. Graham, Shoa L. Clarke, Kuan-Han H. Wu, Stavroula Kanoni, Greg J. M. Zajac, Shweta Ramdas, Ida Surakka, Ioanna Ntalla, Sailaja Vedantam, Thomas W. Winkler, Adam E. Locke, Eirini Marouli, Mi Yeong Hwang, Sohee Han, Akira Narita, Ananyo Choudhury, Amy R. Bentley, Kenneth Ekoru, Anurag Verma, Bhavi Trivedi, Hilary C. Martin, Karen A. Hunt, Qin Hui, Derek Klarin, Xiang Zhu, Gudmar Thorleifsson, Anna Helgadottir, Daniel F. Gudbjartsson, Hilma Holm, Isleifur Olafsson, Masato Akiyama, Saori Sakaue, Chikashi Terao, Masahiro Kanai, Wei Zhou, Ben M. Brumpton, Humaira Rasheed, Sanni E. Ruotsalainen, Aki S. Havulinna, Yogasudha Veturi, QiPing Feng, Elisabeth A. Rosenthal, Todd Lingren, Jennifer Allen Pacheco, Sarah A. Pendergrass, Jeffrey Haessler, Franco Giulianini, Yuki Bradford, Jason E. Miller, Archie Campbell, Kuang Lin, Iona Y. Millwood, George Hindy, Asif Rasheed, Jessica D. Faul, Wei Zhao, David R. Weir, Constance Turman, Hongyan Huang, Mariaelisa Graff, Anubha Mahajan, Michael R. Brown, Weihua Zhang, Ketian Yu, Ellen M. Schmidt, Anita Pandit, Stefan Gustafsson, Xianyong Yin, Jian'an Luan, Jing-Hua Zhao, Fumihiko Matsuda, Hye-Mi Jang, Kyungheon Yoon, Carolina Medina-Gomez, Achilleas Pitsillides, Jouke Jan Hottenga, Gonneke Willemsen, Andrew R. Wood, Yingji Ji, Zishan Gao, Simon Haworth, Ruth E. Mitchell, Jin Fang Chai, Mette Aadahl, Jie Yao, Ani Manichaikul, Helen R. Warren, Julia Ramirez, Jette Bork-Jensen, Line L. Karhus, Anuj Goel, Maria Sabater-Lleal, Raymond Noordam, Carlo Sidore, Edoardo Fiorillo, Aaron F. McDaid, Pedro Marques-Vidal, Matthias Wielscher, Stella Trompet, Naveed Sattar, Line T. Mollehave, Betina H. Thuesen, Matthias Munz, Lingyao Zeng, Jianfeng Huang, Bin Yang, Alaitz Poveda, Azra Kurbasic, Claudia Lamina, Lukas Forer, Markus Scholz, Tessel E. Galesloot, Jonathan P. Bradfield, E. Warwick Daw, Joseph M. Zmuda, Jonathan S. Mitchell, Christian Fuchsberger, Henry Christensen, Jennifer A. Brody, Mary F. Feitosa, Mary K. Wojczynski, Michael Preuss, Massimo Mangino, Paraskevi Christofidou, Niek Verweij, Jan W. Benjamins, Jorgen Engmann, Rachel L. Kember, Roderick C. Slieker, Ken Sin Lo, Nuno R. Zilhao, Phuong Le, Marcus E. Kleber, Graciela E. Delgado, Shaofeng Huo, Daisuke D. Ikeda, Hiroyuki Iha, Jian Yang, Jun Liu, Hampton L. Leonard, Jonathan Marten, Boerge Schmidt, Marina Arendt, Laura J. Smyth, Marisa Canadas-Garre, Chaolong Wang, Masahiro Nakatochi, Andrew Wong, Nina Hutri-Kahonen, Xueling Sim, Rui Xia, Alicia Huerta-Chagoya, Juan Carlos Fernandez-Lopez, Valeriya Lyssenko, Meraj Ahmed, Anne U. Jackson, Noha A. Yousri, Marguerite R. Irvin, Christopher Oldmeadow, Han-Na Kim, Seungho Ryu, Paul R. H. J. Timmers, Liubov Arbeeva, Rajkumar Dorajoo, Leslie A. Lange, Xiaoran Chai, Gauri Prasad, Laura Lores-Motta, Marc Pauper, Jirong Long, Xiaohui Li, Elizabeth Theusch, Fumihiko Takeuchi, Cassandra N. Spracklen, Anu Loukola, Sailalitha Bollepalli, Sophie C. Warner, Ya Xing Wang, Wen B. Wei, Teresa Nutile, Daniela Ruggiero, Yun Ju Sung, Yi-Jen Hung, Shufeng Chen, Fangchao Liu, Jingyun Yang, Katherine A. Kentistou, Mathias Gorski, Marco Brumat, Karina Meidtner, Lawrence F. Bielak, Jennifer A. Smith, Prashantha Hebbar, Aliki-Eleni Farmaki, Edith Hofer, Maoxuan Lin, Chao Xue, Jifeng Zhang, Maria Pina Concas, Simona Vaccargiu, Peter J. van der Most, Niina Pitkanen, Brian E. Cade, Jiwon Lee, Sander W. van der Laan, Kumaraswamy Naidu Chitrala, Stefan Weiss, Martina E. Zimmermann, Jong Young Lee, Hyeok Sun Choi, Maria Nethander, Sandra Freitag-Wolf, Lorraine Southam, Nigel W. Rayner, Carol A. Wang, Shih-Yi Lin, Jun-Sing Wang, Christian Couture, Leo-Pekka Lyytikainen, Kjell Nikus, Gabriel Cuellar-Partida, Henrik Vestergaard, Bertha Hildalgo, Olga Giannakopoulou, Qiuyin Cai, Morgan O. Obura, Jessica van Setten, Xiaoyin Li, Karen Schwander, Natalie Terzikhan, Jae Hun Shin, Rebecca D. Jackson, Alexander P. Reiner, Lisa Warsinger Martin, Zhengming Chen, Liming Li, Heather M. Highland, Kristin L. Young, Takahisa Kawaguchi, Joachim Thiery, Joshua C. Bis, Girish N. Nadkarni, Lenore J. Launer, Huaixing Li, Mike A. Nalls, Olli T. Raitakari, Sahoko Ichihara, Sarah H. Wild, Christopher P. Nelson, Harry Campbell, Susanne Jaeger, Toru Nabika, Fahd Al-Mulla, Harri Niinikoski, Peter S. Braund, Ivana Kolcic, Peter Kovacs, Tota Giardoglou, Tomohiro Katsuya, Konain Fatima Bhatti, Dominique de Kleijn, Gert J. de Borst, Eung Kweon Kim, Hieab H. H. Adams, M. Arfan Ikram, Xiaofeng Zhu, Folkert W. Asselbergs, Adriaan O. Kraaijeveld, Joline W. J. Beulens, Xiao-Ou Shu, Loukianos S. Rallidis, Oluf Pedersen, Torben Hansen, Paul Mitchell, Alex W. Hewitt, Mika Kahonen, Louis Perusse, Claude Bouchard, Anke Toenjes, Yii-Der Ida Chen, Craig E. Pennell, Trevor A. Mori, Wolfgang Lieb, Andre Franke, Claes Ohlsson, Dan Mellstrom, Yoon Shin Cho, Hyejin Lee, Jian-Min Yuan, Woon-Puay Koh, Sang Youl Rhee, Jeong-Taek Woo, Iris M. Heid, Klaus J. Stark, Henry Voelzke, Georg Homuth, Michele K. Evans, Alan B. Zonderman, Ozren Polasek, Gerard Pasterkamp, Imo E. Hoefer, Susan Redline, Katja Pahkala, Albertine J. Oldehinkel, Harold Snieder, Ginevra Biino, Reinhold Schmidt, Helena Schmidt, Y. Eugene Chen, Stefania Bandinelli, George Dedoussis, Thangavel Alphonse Thanaraj, Sharon L. R. Kardia, Norihiro Kato, Matthias B. Schulze, Giorgia Girotto, Bettina Jung, Carsten A. Boeger, Peter K. Joshi, David A. Bennett, Philip L. De Jager, Xiangfeng Lu, Vasiliki Mamakou, Morris Brown, Mark J. Caulfield, Patricia B. Munroe, Xiuqing Guo, Marina Ciullo, Jost B. Jonas, Nilesh J. Samani, Jaakko Kaprio, Paeivi Pajukanta, Linda S. Adair, Sonny Augustin Bechayda, H. Janaka de Silva, Ananda R. Wickremasinghe, Ronald M. Krauss, Jer-Yuarn Wu, Wei Zheng, Anneke I. den Hollander, Dwaipayan Bharadwaj, Adolfo Correa, James G. Wilson, Lars Lind, Chew-Kiat Heng, Amanda E. Nelson, Yvonne M. Golightly, James F. Wilson, Brenda Penninx, Hyung-Lae Kim, John Attia, Rodney J. Scott, D. C. Rao, Donna K. Arnett, Steven C. Hunt, Mark Walker, Heikki A. Koistinen, Giriraj R. Chandak, Chittaranjan S. Yajnik, Josep M. Mercader, Teresa Tusie-Luna, Carlos A. Aguilar-Salinas, Clicerio Gonzalez Villalpando, Lorena Orozco, Myriam Fornage, E. Shyong Tai, Rob M. van Dam, Terho Lehtimaki, Nish Chaturvedi, Mitsuhiro Yokota, Jianjun Liu, Dermot F. Reilly, Amy Jayne McKnight, Frank Kee, Karl-Heinz Joeckel, Mark I. McCarthy, Colin N. A. Palmer, Veronique Vitart, Caroline Hayward, Eleanor Simonsick, Cornelia M. van Duijn, Fan Lu, Jia Qu, Haretsugu Hishigaki, Xu Lin, Winfried Maerz, Esteban J. Parra, Miguel Cruz, Vilmundur Gudnason, Jean-Claude Tardif, Guillaume Lettre, Leen M. 't Hart, Petra J. M. Elders, Scott M. Damrauer, Meena Kumari, Mika Kivimaki, Pim van der Harst, Tim D. Spector, Ruth J. F. Loos, Michael A. Province, Bruce M. Psaty, Ivan Brandslund, Peter P. Pramstaller, Kaare Christensen, Samuli Ripatti, Elisabeth Widen, Hakon Hakonarson, Struan F. A. Grant, Lambertus A. L. M. Kiemeney, Jacqueline de Graaf, Markus Loeffler, Florian Kronenberg, Dongfeng Gu, Jeanette Erdmann, Heribert Schunkert, Paul W. Franks, Allan Linneberg, J. Wouter Jukema, Amit V. Khera, Minna Mannikko, Marjo-Riitta Jarvelin, Zoltan Kutalik, Francesco Cucca, Dennis O. Mook-Kanamori, Ko Willems van Dijk, Hugh Watkins, David P. Strachan, Niels Grarup, Peter Sever, Neil Poulter, Jerome I. Rotter, Thomas M. Dantoft, Fredrik Karpe, Matt J. Neville, Nicholas J. Timpson, Ching-Yu Cheng, Tien-Yin Wong, Chiea Chuen Khor, Charumathi Sabanayagam, Annette Peters, Christian Gieger, Andrew T. Hattersley, Nancy L. Pedersen, Patrik K. E. Magnusson, Dorret I. Boomsma, Eco J. C. de Geus, L. Adrienne Cupples, Joyce B. J. van Meurs, Mohsen Ghanbari, Penny Gordon-Larsen, Wei Huang, Young Jin Kim, Yasuharu Tabara, Nicholas J. Wareham, Claudia Langenberg, Eleftheria Zeggini, Johanna Kuusisto, Markku Laakso, Erik Ingelsson, Goncalo Abecasis, John C. Chambers, Jaspal S. Kooner, Paul S. de Vries, Alanna C. Morrison, Kari E. North, Martha Daviglus, Peter Kraft, Nicholas G. Martin, John B. Whitfield, Shahid Abbas, Danish Saleheen, Robin G. Walters, Michael V. Holmes, Corri Black, Blair H. Smith, Anne E. Justice, Aris Baras, Julie E. Buring, Paul M. Ridker, Daniel I. Chasman, Charles Kooperberg, Wei-Qi Wei, Gail P. Jarvik, Bahram Namjou, M. Geoffrey Hayes, Marylyn D. Ritchie, Pekka Jousilahti, Veikko Salomaa, Kristian Hveem, Bjorn Olav Asvold, Michiaki Kubo, Yoichiro Kamatani, Yukinori Okada, Yoshinori Murakami, Unnur Thorsteinsdottir, Kari Stefansson, Yuk-Lam Ho, Julie A. Lynch, Daniel J. Rader, Philip S. Tsao, Kyong-Mi Chang, Kelly Cho, Christopher J. O'Donnell, John M. Gaziano, Peter Wilson, Charles N. Rotimi, Scott Hazelhurst, Michele Ramsay, Richard C. Trembath, David A. van Heel, Gen Tamiya, Masayuki Yamamoto, Bong-Jo Kim, Karen L. Mohlke, Timothy M. Frayling, Joel N. Hirschhorn, Sekar Kathiresan, Michael Boehnke, Pradeep Natarajan, Gina M. Peloso, Christopher D. Brown, Andrew P. Morris, Themistocles L. Assimes, Panos Deloukas, Yan V. Sun, Cristen J. Willer

NATURE (2023)

Article Oncology

Delta tocotrienol as a supplement to FOLFOXIRI in first-line treatment of metastatic colorectal cancer. A randomized, double-blind, placebo-controlled phase II study

Louise Raunkilde, Torben Frostrup Hansen, Birgitte Mayland Havelund, Caroline Brenner Thomsen, Soren Rafael Rafaelsen, Jan Lindebjerg, Lars Henrik Jensen

Summary: This study investigated whether adding δ-tocotrienol, a vitamin E analogue, to triplet chemotherapy reduces its toxicity. The results showed that δ-tocotrienol did not significantly prolong the time to first hospitalization or death, but it may have a neuroprotective effect on oxaliplatin.

ACTA ONCOLOGICA (2023)

Review Oncology

Methylated Circulating Tumor DNA in Blood as a Tool for Diagnosing Lung Cancer: A Systematic Review and Meta-Analysis

Morten Borg, Sara Witting Christensen Wen, Rikke Fredslund Andersen, Signe Timm, Torben Frostrup Hansen, Ole Hilberg

Summary: Lung cancer is the leading cause of cancer-related deaths, and early detection is crucial for improving patient outcomes. Non-invasive diagnostic tools, such as methylated circulating tumor DNA (ctDNA), show potential for lung cancer diagnosis. This systematic review and meta-analysis evaluated the current evidence on the use of methylated ctDNA in blood samples as a diagnostic tool for lung cancer.

CANCERS (2023)

Meeting Abstract Oncology

International validation of the Immunoscore-biopsy (ISB) to guide selection and monitoring of patients treated with watch-and-wait (WW) strategy for rectal cancer.

Franck Pages, Carine El Sissy, Amos Kirilovsky, Petra Custers, Edina Dizdarevic, Christine Lagorce, Mireia Castillo-Martin, Jose van den Berg, Soledad Iseas, Fernando Sanchez Loria, Jean-Pierre Gerard, Gabriel Dimofte, Rodrigo O. Perez, Angelita Habr-Gama, Nuno Figueiredo, Torben Hansen, Myriam Chalabi, Jerome Galon, Geerard Beets, Guy Zeitoun

JOURNAL OF CLINICAL ONCOLOGY (2022)

Meeting Abstract Critical Care Medicine

Aid of a Blood Biomarker Panel in Lung Cancer Screening Criteria

M. Borg, S. Wen, L. Nederby, T. Hansen, A. Jakobsen, R. Andersen, U. M. Weinreich, O. Hilberg

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2022)

Article Oncology

CT and 3 Tesla MRI in the TN Staging of Colon Cancer: A Prospective, Blind Study

Soren R. Rafaelsen, Claus Dam, Chris Vagn-Hansen, Jakob Moller, Hans B. Rahr, Mikkel Sjoestroem, Jan Lindebjerg, Torben Frostrup Hansen, Malene Roland Vils Pedersen

Summary: This study compared the sensitivity and specificity of MRI and CT in the staging of colon cancer. The results showed that MRI had significantly higher sensitivity than CT in detecting advanced T3cd and T4 tumors. MRI has the potential to be utilized in the treatment planning of colon cancer.

CURRENT ONCOLOGY (2022)

No Data Available